HHS/ASPR established threshold levels for ordering COVID-19 therapeutics available to each jurisdiction. From September 5, 2022 to January 29, 2023 available therapeutics included: Paxlovid, Lagevrio, and Evusheld (see the table below for threshold values). The table below is available for archival purposes only.
To find out how HHS/ASPR is currently bringing COVID-19 therapeutics to your state or territory, see
COVID-19 Therapeutics Thresholds, Orders, and Replenishment by Jurisdiction.
COVID-19 Therapeutics Threshold Determinations
September 5, 2022 - January 29, 2023
|
Paxlovid (Standard and Renal) |
Lagevrio (molnupiravir) |
Evusheld |
Total |
January 23 - January 29, 2023 |
612,115 |
48,296 |
0 |
660,411 |
January 16 - January 22, 2023 |
612,115 |
48,296 |
0 |
660,411 |
January 9 - January 15, 2023 |
612,060 |
48,240 |
0 |
660,300 |
January 2 - January 8, 2023 |
613,580 |
48,735 |
204,096 |
866,411 |
December 26, 2022 - January 1, 2023 |
612,060 |
48,240 |
0 |
660,300 |
December 19 - December 25, 2022 |
612,060 |
48,240 |
0 |
660,300 |
December 12 - December 18, 2022 |
612,060 |
48,240 |
0 |
660,300 |
December 5 - December 11, 2022 |
613,580 |
48,735 |
204,096 |
866,411 |
November 28 - December 4, 2022 |
612,060 |
48,240 |
0 |
660,300 |
November 21 - November 27, 2022 |
612,060 |
48,240 |
0 |
660,300 |
November 14 - November 20, 2022 |
612,060 |
48,240 |
0 |
660,300 |
November 7 - November 13, 2022 |
612,060 |
48,240 |
0 |
660,300 |
October 31 - November 6, 2022 |
613,580 |
48,735 |
204,096 |
866,411 |
October 24 - October 30, 2022 |
612,060 |
48,240 |
0 |
660,300 |
October 17 - October 23, 2022 |
612,060 |
48,240 |
0 |
660,300 |
October 10 - October 16, 2022 |
612,060 |
48,240 |
0 |
660,300 |
October 3 - October 9, 2022 |
613,580 |
48,735 |
204,096 |
866,411 |
September 26 - October 2, 2022 |
612,060 |
48,312 |
0 |
660,372 |
September 19 - September 25, 2022 |
612,060 |
91,920 |
0 |
703,980 |
September 12 - September 18, 2022 |
612,060 |
91,920 |
0 |
703,980 |
September 5 - September 11, 2022 |
612,060 |
91,920 |
0 |
703,980 |
Other Prior COVID-19 Therapeutic Product Distribution Efforts